1 Foley G,Alston R,Geraci M,et al.Increasing rates of cervical cancer in young women in England:an analysis of national data 1982–2006,Br J Cancer,2011,105:177-184.
2 Nahvijou A,Hadji M,Marnani AB,et al.A systematic review of economic aspects of cervical cancer screening strategies worldwide:discrepancy between economic analysis and policymaking.Asian Pac J Cancer P,2014,15:8229-8237.
3 乔友林,赵宇倩.宫颈癌的流行病学现状和预防.中华妇幼临床医学杂志(电子版),2015,11:1-6.
4 Siegel EM,Riggs BM,Delmas AL,et al.Quantitative DNA methylation analysis of candidate genes in cervical cancer.PLoS ONE,2015,10:122-123.
5 Bhat S,Kabekkodu SP,Varghese VK,et al.Aberrant gene-specific DNA methylation signature analysis in cervical cancer.Tumor Biol,2017,39:1-16.
6 Bu Q,Wang S,Ma J,etal.The clinical significance of FAM19A4 methylation in high-risk HPV-positive cervical samples for the detection of cervical (pre)cancer in Chinese women.Bmc Cancer,2018,18:1182-1185.
7 Schmitz M,Eichelkraut K,Schmidt D,et al.Performance of a DNA methylation marker panel using liquid-based cervical scrapes to detect cervical cancer and its precancerous stages.Bmc Cancer,2018,18:1197-1205.
8 Su HY,Lai HC,Lin YW,et al.An epigenetic marker panel for screening and prognostic prediction of ovarian cancer.Int J Cancer,2009,124:387-393.
9 Lin CJ,Lai HC,Wang KH,et al.Testing for methylated PCDH10 or WT1 is superior to the HPV test in detecting severe neoplasms (CIN3 or greater) in the triage of ASC-US smear results.AM J Obstet Gynecol,2011,204:21-27.
10 Narayan G,Scotto L,Neelakantan V,et al.Protocadherin PCDH10,involved in tumor progression,is a frequent and early target of promoter hypermethylation in cervical cancer.Gene Chromosome Canc,2010,48:983-992.
11 Huntley S,Baggott DM,Hamilton AT,et al.A comprehensive catalog of human KRAB-associated zinc finger genes:insights into the evolutionary history of a large family of transcriptional repressors.Genome Res,2006,16:669-677.
